PAR
Click for more information
0.00% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4101

  1. TanamiRod
    547 Posts.
    lightbulb Created with Sketch. 218
    clock Created with Sketch.
    24/05/24
    06:29
    Post #: 73985114
    Nice fund jcurve... So our friends at Bene are not just relying on PAR to assist in their potential growth, via pain from OA. Smart cookies.

    Interesting dosing regiment at 10mg/kg, just doesn't state how often.. It looks to be in a similar ballpark as Elmiron, which we know was BAD
    PAR Price at posting: 24.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $87.44M
Open High Low Value Volume
24.5¢ 25.5¢ 24.5¢ $93.31K 373.6K

Buyers (Bids)

No. Vol. Price($)
5 346482 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 114261 4
View Market Depth
Last trade - 12.03pm 26/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.